SyMRI NEURO

SyntheticMR

The product package SyMRI NEURO includes contrast weighted images as well as biomarker segmentation, volumetric measurements of brain tissues and parametric maps. The product is designed to offer the clinician more information than conventional MRI and provide objective decision support for the diagnosis and follow-up of patients.

Information source: Public
Last updated: January 30, 2020

General Information

General
Product name	SyMRI NEURO
Company	SyntheticMR
Subspeciality	Neuro
Modality	MR
Disease targeted	Multiple sclerosis, atrophy, dementia, neurogenerative diseases
Key-features	Contrast image synthesis, brain region segmentation, degree of myelination,
Suggested use

Technical Specifications

Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time

Regulatory

Certification
CE	Certified, Class IIa , MDD
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since	04-2017
Distribution channels	GE Healthcare, Siemens Healthineers (syngo.via and marketplace)
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers